Xilio Therapeutics, Inc. (XLO)
0.7103
-0.01
(-1.09%)
USD |
NASDAQ |
Dec 11, 16:00
0.7245
+0.01
(+2.00%)
Pre-Market: 20:00
Xilio Therapeutics Shareholders Equity (Quarterly): -8.095M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| BioXcel Therapeutics, Inc. | -88.92M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.69M |
| Total Liabilities (Quarterly) | 141.79M |
| Debt to Equity Ratio | -0.8972 |
| Current Ratio | 2.200 |
| Net Debt Paydown Yield | 0.65% |